| Dr Alan D Gaines, MD | |
|
106 Nate Whipple Hwy, Suite 201, Cumberland, RI 02864-1403 | |
| (401) 658-1800 | |
| (401) 658-2322 |
| Full Name | Dr Alan D Gaines |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 106 Nate Whipple Hwy, Cumberland, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841397981 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD07370 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Entity Name | Robert J Settipane |
|---|---|
| Entity Type | Practitioner - Allergy/immunology |
| Entity Identifiers | NPI Number: 1750456042 PECOS PAC ID: 6608773882 Enrollment ID: I20040203000617 |
News Archive
Researchers from King's College London have identified the brain activity for the first time in a newborn baby when they are learning an association between different types of sensory experiences.
As states seek to keep spending down for the health care program for low-income and disabled residents, they look to trim reimbursement rates and move more enrollees to private plans that control costs.
Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.
Everyone wants a dignified death - yet few actually experience one. Despite preferring to remain at home, most older adults spend their final days in hospitals, where they often undergo medical care that neither improves survival nor quality of life.
› Verified 8 days ago
| Entity Name | Russell A Settipane |
|---|---|
| Entity Type | Practitioner - Allergy/immunology |
| Entity Identifiers | NPI Number: 1053470476 PECOS PAC ID: 5496738544 Enrollment ID: I20080428000211 |
News Archive
Researchers from King's College London have identified the brain activity for the first time in a newborn baby when they are learning an association between different types of sensory experiences.
As states seek to keep spending down for the health care program for low-income and disabled residents, they look to trim reimbursement rates and move more enrollees to private plans that control costs.
Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.
Everyone wants a dignified death - yet few actually experience one. Despite preferring to remain at home, most older adults spend their final days in hospitals, where they often undergo medical care that neither improves survival nor quality of life.
› Verified 8 days ago
| Entity Name | Allergy & Asthma Center Of Providence |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144389560 PECOS PAC ID: 3779566823 Enrollment ID: O20040609001406 |
News Archive
Researchers from King's College London have identified the brain activity for the first time in a newborn baby when they are learning an association between different types of sensory experiences.
As states seek to keep spending down for the health care program for low-income and disabled residents, they look to trim reimbursement rates and move more enrollees to private plans that control costs.
Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.
Everyone wants a dignified death - yet few actually experience one. Despite preferring to remain at home, most older adults spend their final days in hospitals, where they often undergo medical care that neither improves survival nor quality of life.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alan D Gaines, MD 106 Nate Whipple Hwy, Suite 201, Cumberland, RI 02864-1403 Ph: (401) 658-1800 | Dr Alan D Gaines, MD 106 Nate Whipple Hwy, Suite 201, Cumberland, RI 02864-1403 Ph: (401) 658-1800 |
News Archive
Researchers from King's College London have identified the brain activity for the first time in a newborn baby when they are learning an association between different types of sensory experiences.
As states seek to keep spending down for the health care program for low-income and disabled residents, they look to trim reimbursement rates and move more enrollees to private plans that control costs.
Ramot, Tel Aviv University's technology transfer company, and Neovii, a Swiss-based biopharmaceutical company and a member of Israel-based Neopharm Group, announced today that they have signed a research and license agreement to develop a novel and potentially life-saving COVID-19 vaccine.
Everyone wants a dignified death - yet few actually experience one. Despite preferring to remain at home, most older adults spend their final days in hospitals, where they often undergo medical care that neither improves survival nor quality of life.
› Verified 8 days ago